NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 221 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
Login
Register & Pricing
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Robert Gray
Harvard University - Cambridge / United States
Medical and Health Sciences / Biostatistics
AD Scientific Index ID: 1391420
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Robert Gray's MOST POPULAR ARTICLES
1-)
A proportional hazards model for the subdistribution of a competing riskJP Fine, RJ GrayJournal of the American statistical association 94 (446), 496-509, 1999115091999
2-)
Paclitaxel–carboplatin alone or with bevacizumab for non–small-cell lung cancerA Sandler, R Gray, MC Perry, J Brahmer, JH Schiller, A Dowlati, ...New England Journal of Medicine 355 (24), 2542-2550, 200670592006
3-)
A class of K-sample tests for comparing the cumulative incidence of a competing riskRJ GrayThe Annals of statistics, 1141-1154, 198848131988
4-)
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trialsEarly Breast Cancer Trialists\' Collaborative GroupThe Lancet 379 (9814), 432-444, 201223132012
5-)
Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancerJA Sparano, RJ Gray, DF Makower, KI Pritchard, KS Albain, DF Hayes, ...New England Journal of Medicine 379 (2), 111-121, 201822862018
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept